TEVA logo

TEVA Return On Equity

Annual ROE:

-28.43%-21.08%(-286.80%)
December 31, 2024

Summary

  • As of today, TEVA annual return on equity is -28.43%, with the most recent change of -21.08% (-286.80%) on December 31, 2024.
  • During the last 3 years, TEVA annual ROE has fallen by -32.52% (-795.11%).
  • TEVA annual ROE is now -203.46% below its all-time high of 27.48%, reached on March 31, 1987.

Performance

1-Year Change

-286.8%

3-Year Change

-795.11%

5-Year Change

-338.73%

15-Year Change

+53.91%

TEVA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

58.72%
TEVA annual return on equity is higher than 58.72% of companies in Healthcare sector

Range

All-Time High

27.48%
TEVA annual return on equity is currently -203.46% below its historical high of 27.48%

3-Year Low

-28.43%
TEVA annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TEVA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Jan 28, 2026
TEVA next annual earnings announcement is scheduled for Jan 28, 2026

OtherTEVAprofitability metrics

Annual Revenue

$16.59B
TEVA annual revenue is $16.59 billion

Annual Net Income

-$1.97B
TEVA annual net profit is -$1.97 billion

Annual EPS

-$1.46
TEVA annual earnings per share is -$1.46

Annual ROA

-4.75%
TEVA annual return on assets is -4.75%

Quarterly ROE:

10.27%+12.78%(+509.16%)
September 30, 2025

Summary

  • As of today, TEVA quarterly return on equity is 10.27%, with the most recent change of +12.78% (+509.16%) on September 30, 2025.
  • Over the past year, TEVA quarterly ROE has increased by +27.11% (+160.99%).
  • TEVA quarterly ROE is now -68.37% below its all-time high of 32.47%, reached on September 30, 2003.

Performance

3-Month Change

+509.16%

1-Year Change

+160.99%

3-Year Change

+182.42%

5-Year Change

+134.35%

TEVA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

78.44%
TEVA quarterly return on equity is higher than 78.44% of companies in Healthcare sector

Range

All-Time High

32.47%
TEVA quarterly return on equity is currently -68.37% below its historical high of 32.47%

3-Year Low

-28.61%
TEVA quarterly return on equity is currently +135.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
TEVA previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Jan 28, 2026
TEVA next earnings announcement is scheduled for Jan 28, 2026

OtherTEVAprofitability metrics

Quarterly Revenue

$4.49B
TEVA quarterly revenue is $4.49 billion

Quarterly Net Income

$436.03M
TEVA quarterly net profit is $436.03 million

Quarterly EPS

$0.37
TEVA quarterly earnings per share is $0.37

Quarterly ROA

1.67%
TEVA quarterly return on assets is 1.67%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

-28.43%
TEVA annual return on equity is -28.43%

Annual Net Income

-$1.97B
TEVA annual net profit is -$1.97 billion

Annual Shareholders Equity

$5.37B
TEVA annual stockholders equity is $5.37 billion

TEVA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-286.8%+161.0%
3Y3 Years-795.1%+182.4%
5Y5 Years-338.7%+134.3%

TEVA ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-795.1%at lowat high+135.9%
5Y5-Year-795.1%+9.4%at high+131.2%
All-TimeAll-Time-203.5%+53.9%-68.4%+117.2%

TEVA ROE History

DateAnnualQuarterly
Sep 2025
-
10.27%(+509.2%)
Jun 2025
-
-2.51%(+87.7%)
Mar 2025
-
-20.34%(+28.7%)
Dec 2024
-28.43%(-286.8%)
-28.54%(-69.5%)
Sep 2024
-
-16.84%(-67.9%)
Jun 2024
-
-10.03%(-2.6%)
Mar 2024
-
-9.78%(-31.3%)
Dec 2023
-7.35%(+70.7%)
-7.45%(+74.0%)
Sep 2023
-
-28.61%(-4.8%)
Jun 2023
-
-27.29%(-43.6%)
Mar 2023
-
-19.01%(+24.2%)
Dec 2022
-25.09%(-713.4%)
-25.09%(-101.4%)
Sep 2022
-
-12.46%(-26.9%)
Jun 2022
-
-9.82%(-86.7%)
Mar 2022
-
-5.26%(-229.6%)
Dec 2021
4.09%(+113.0%)
4.06%(-41.5%)
Sep 2021
-
6.94%(+121.1%)
Jun 2021
-
-32.94%(-1.2%)
Mar 2021
-
-32.55%(-5.0%)
Dec 2020
-31.39%(-384.4%)
-30.99%(-3.6%)
Sep 2020
-
-29.90%(-2775.0%)
Jun 2020
-
-1.04%(+82.1%)
Mar 2020
-
-5.81%(+10.8%)
Dec 2019
-6.48%(+54.6%)
-6.51%(+75.5%)
Sep 2019
-
-26.55%(-8.3%)
Jun 2019
-
-24.52%(-20.3%)
Mar 2019
-
-20.39%(-55.1%)
Dec 2018
-14.27%(+76.9%)
-13.15%(+74.3%)
Sep 2018
-
-51.14%(-18.4%)
Jun 2018
-
-43.18%(+27.7%)
Mar 2018
-
-59.76%(-7.8%)
Dec 2017
-61.69%(-6526.0%)
-55.42%(-223.1%)
Sep 2017
-
-17.15%(+2.4%)
Jun 2017
-
-17.57%(-1930.2%)
Mar 2017
-
0.96%(+2.1%)
Dec 2016
0.96%(-84.0%)
0.94%(-83.9%)
Sep 2016
-
5.85%(+8.9%)
Jun 2016
-
5.37%(-22.3%)
Mar 2016
-
6.91%(+5.5%)
Dec 2015
5.99%(-54.7%)
6.55%(-15.5%)
Sep 2015
-
7.75%(-29.0%)
Jun 2015
-
10.91%(-7.5%)
Mar 2015
-
11.80%(-9.8%)
Dec 2014
13.23%(+140.1%)
13.08%(+10.4%)
Sep 2014
-
11.85%(+3.3%)
Jun 2014
-
11.47%(+87.1%)
Mar 2014
-
6.13%(+7.4%)
Dec 2013
5.51%(-34.6%)
5.71%(+9.4%)
Sep 2013
-
5.22%(+220.2%)
Jun 2013
-
1.63%(-77.7%)
Mar 2013
-
7.32%(-9.6%)
Dec 2012
8.42%(-32.2%)
8.10%(-9.8%)
Sep 2012
-
8.98%(-32.2%)
Jun 2012
-
13.24%(+8.5%)
Mar 2012
-
12.20%(+0.2%)
Dec 2011
12.41%(-23.2%)
12.17%(-10.0%)
Sep 2011
-
13.52%(-7.0%)
Jun 2011
-
14.53%(-9.5%)
Mar 2011
-
16.05%(-1.7%)
Dec 2010
16.15%(+44.8%)
16.32%(+10.0%)
Sep 2010
-
14.84%(+11.1%)
Jun 2010
-
13.36%(+9.1%)
Mar 2010
-
12.25%(+8.8%)
Dec 2009
11.15%(+174.0%)
11.26%(+105.9%)
Sep 2009
-
5.47%(-4.9%)
Jun 2009
-
5.75%(-5.6%)
Mar 2009
-
6.09%(+45.3%)
Dec 2008
4.07%(-73.8%)
4.19%(-68.7%)
Sep 2008
-
13.40%(+2.5%)
Jun 2008
-
13.07%(-5.7%)
Mar 2008
-
13.86%(-14.4%)
Dec 2007
15.56%(+146.2%)
16.19%(+1.6%)
Sep 2007
-
15.93%(-9.1%)
Jun 2007
-
17.53%(-2.8%)
Mar 2007
-
18.04%(+215.4%)
Dec 2006
6.32%
5.72%(+26.0%)
DateAnnualQuarterly
Sep 2006
-
4.54%(+866.0%)
Jun 2006
-
0.47%(+114.1%)
Mar 2006
-
-3.33%(-117.3%)
Dec 2005
18.80%(+143.5%)
19.24%(-2.5%)
Sep 2005
-
19.73%(-3.1%)
Jun 2005
-
20.36%(-2.4%)
Mar 2005
-
20.87%(+179.8%)
Dec 2004
7.72%(-71.2%)
7.46%(+20.7%)
Sep 2004
-
6.18%(+34.9%)
Jun 2004
-
4.58%(-10.5%)
Mar 2004
-
5.12%(-83.0%)
Dec 2003
26.85%(+4.6%)
30.16%(-7.1%)
Sep 2003
-
32.47%(+2.7%)
Jun 2003
-
31.62%(+18.6%)
Mar 2003
-
26.66%(+4.4%)
Dec 2002
25.66%(+17.2%)
25.54%(+9.2%)
Sep 2002
-
23.39%(-0.6%)
Jun 2002
-
23.52%(+0.7%)
Mar 2002
-
23.36%(+6.4%)
Dec 2001
21.89%(+210.5%)
21.96%(+37.0%)
Sep 2001
-
16.03%(-16.4%)
Jun 2001
-
19.17%(+22.4%)
Mar 2001
-
15.66%(+2.3%)
Dec 2000
7.05%(-57.8%)
15.31%(+1.8%)
Sep 2000
-
15.04%(+15.4%)
Jun 2000
-
13.03%(-25.8%)
Mar 2000
-
17.55%(+59.7%)
Dec 1999
16.69%(+7.1%)
-
Dec 1998
15.58%(-12.0%)
-
Sep 1998
-
10.99%(-18.4%)
Jun 1998
-
13.46%(-26.2%)
Mar 1998
-
18.25%(-19.3%)
Dec 1997
17.71%(+14.4%)
22.62%(-8.1%)
Sep 1997
-
24.62%(+10.0%)
Jun 1997
-
22.39%(+44.8%)
Mar 1997
-
15.46%(-21.8%)
Dec 1996
15.48%(-29.4%)
19.78%(+78.4%)
Sep 1996
-
11.09%(+4.5%)
Jun 1996
-
10.61%(-30.5%)
Mar 1996
-
15.27%(-34.7%)
Dec 1995
21.94%(-6.6%)
23.38%(+6.8%)
Sep 1995
-
21.90%(+5.8%)
Jun 1995
-
20.70%(+1.9%)
Mar 1995
-
20.32%(-30.8%)
Dec 1994
23.49%(-6.3%)
29.38%(+13.9%)
Sep 1994
-
25.79%(+5.5%)
Jun 1994
-
24.45%(+7.0%)
Mar 1994
-
22.84%(-26.2%)
Dec 1993
25.07%(+60.6%)
30.95%(+32.5%)
Sep 1993
-
23.35%(+16.1%)
Jun 1993
-
20.11%(+18.3%)
Mar 1993
-
17.00%(-19.2%)
Dec 1992
15.61%(+4.9%)
21.05%(+35.2%)
Sep 1992
-
15.57%(+7.6%)
Jun 1992
-
14.47%(+0.8%)
Mar 1992
-
14.36%(-27.9%)
Dec 1991
14.88%(-8.8%)
19.92%(+3.1%)
Sep 1991
-
19.32%(+4.8%)
Jun 1991
-
18.44%(+14.2%)
Mar 1991
-
16.15%(-29.6%)
Dec 1990
16.31%(+5.4%)
22.95%(+64.0%)
Sep 1990
-
13.99%(0.0%)
Jun 1990
-
13.99%(+1.2%)
Mar 1990
-
13.82%(-33.3%)
Dec 1989
15.47%(+1.1%)
20.72%(+40.7%)
Sep 1989
-
14.73%(+10.6%)
Jun 1989
-
13.32%(-0.7%)
Mar 1989
-
13.42%(-22.9%)
Dec 1988
15.30%(-44.3%)
17.41%(-22.6%)
Sep 1987
-
22.49%(-6.5%)
Jun 1987
-
24.05%(-6.1%)
Mar 1987
27.48%(+80.4%)
25.61%(-1.7%)
Dec 1986
-
26.05%(+16.1%)
Sep 1986
-
22.44%(+19.1%)
Jun 1986
-
18.84%(+23.7%)
Mar 1986
15.23%
15.23%

FAQ

  • What is Teva Pharmaceutical Industries Limited annual return on equity?
  • What is the all-time high annual ROE for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual ROE year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly return on equity?
  • What is the all-time high quarterly ROE for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly ROE year-on-year change?

What is Teva Pharmaceutical Industries Limited annual return on equity?

The current annual ROE of TEVA is -28.43%

What is the all-time high annual ROE for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual return on equity is 27.48%

What is Teva Pharmaceutical Industries Limited annual ROE year-on-year change?

Over the past year, TEVA annual return on equity has changed by -21.08% (-286.80%)

What is Teva Pharmaceutical Industries Limited quarterly return on equity?

The current quarterly ROE of TEVA is 10.27%

What is the all-time high quarterly ROE for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly return on equity is 32.47%

What is Teva Pharmaceutical Industries Limited quarterly ROE year-on-year change?

Over the past year, TEVA quarterly return on equity has changed by +27.11% (+160.99%)
On this page